Mycobacterium reverse hybridization line-probe assay used to diagnose disseminated Mycobacterium haemophilum infection in a child with acute lymphoblastic leukemia.
Bosma
F
F
Department of Medical Microbiology, University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. F.Bosma@mmb.umcn.nl
Deckers-Kocken
J M
JM
de Graaf
S S N
SS
Schülin
T
T
Melchers
W J G
WJ
Hoogkamp-Korstanje
J A
JA
D000995:Antitubercular Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D008826:Microbial Sensitivity Tests; D009164:Mycobacterium Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D018393:Mycobacterium haemophilum / Q000302:isolation & purification*; D009693:Nucleic Acid Hybridization / Q000379:methods*; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000276:immunology*; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D000995:Antitubercular Agents